Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Incopro is a leading provider of online brand protection and intellectual property (IP) software solutions. The company's flagship platform, Talisman, utilizes advanced data analytics and machine learning to identify, prioritize, and remove counterfeit listings and IP infringements across global digital channels. While not a life sciences company itself, Incopro frequently partners with major pharmaceutical and healthcare companies to protect their brands and patient safety from illicit online trade. Its technology is specifically designed to monitor marketplaces, social media, and rogue websites to ensure that consumers are not exposed to fake or dangerous medical products. In June 2021, Incopro was acquired by Corsearch, a global leader in trademark and brand protection solutions, to create a comprehensive suite of IP management tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Incopro.